Study of Lotilaner Ophthalmic Gel in Patients With Ocular Rosacea (KORE)

计划入组 155 人 · 首次发布于 2026 年 3 月 2 日

Study of TP-04 in Participants With Papulopustular Rosacea

计划入组 37 人 · 首次发布于 2023 年 5 月 1 日

Impact of XDEMVY® on Demodex Blepharitis in Soft Contact Lens Wearers

计划入组 145 人 · 首次发布于 2023 年 12 月 26 日

Lotilaner(Xdemvy)

C₂₀H₁₄Cl₃F₆N₃O₃S

Ophthalmic diseases(Spotlight)

Timolol ophthalmic (Betaliq)

Sol-Gel Technologies

Israel

Sol-Gel Technologies, Inc.

United States

ATHLETES GEL PTY. LTD.

Australia

Tarsus Pharmaceuticals Advances Ocular Rosacea Program and Accelerates XDEMVY Launch

Elanco's Credelio Quattro Receives FDA Approval for Broad-Spectrum Parasite Protection in Dogs

FDA Grants First Emergency Use Authorization for Lotilaner to Treat New World Screwworm in Dogs